Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3671-3680 of 4090 results

Catalogue Number:

PX-TA1638

Category:

G

Proteo Genix logo

Penpulimab Biosimilar – Anti-Pd-1 mAb – Research Grade

Target: Pd-1
Target Alias Name: Penpulimab /anti-(human programmed cell death 1) monoclonal antibody/Pd-1/anti-Pd-1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: Human IgG
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1382

Category:

G

Proteo Genix logo

Pepinemab Biosimilar – Anti-SEMA4D mAb – Research Grade

Target: SEMA4D
Target Alias Name: Pepinemab /VX-15/VX15/2503/SEMA4D/anti-SEMA4D
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1301

Category:

G

Proteo Genix logo

Perakizumab Biosimilar – Anti-IL17A mAb – Research Grade

Target: IL17A
Target Alias Name: Perakizumab/RG4934/RO5310074/IL17A/anti-IL17A
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2081

Category:

G

Proteo Genix logo

Perenostobart Biosimilar – Anti-ENTPD1 mAb – Research Grade

Target: ENTPD1
Target Alias Name: anti-ENTPD1/ Ecto-ATP diphosphohydrolase 1/ NTPDase 1/ Ecto-ATPase 1/ Ecto-apyrase/ Ecto-ATPDase 1/ Ectonucleoside triphosphate diphosphohydrolase 1/ CD39/ Lymphoid cell activation antigen
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1876

Category:

G

Proteo Genix logo

Peresolimab Biosimilar – Anti-PDCD1 mAb – Research Grade

Target: PDCD1
Target Alias Name: Peresolimab//PDCD1/anti-PDCD1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1058

Category:

G

Proteo Genix logo

Pertuzumab Biosimilar – Anti-ERBB2/ EGFR2/ CD340 mAb – Research Grade

Target: ERBB2/ EGFR2/ CD340
Target Alias Name: Pertuzumab/OMNITARG/rhuMAB 2C4/ERBB2/ EGFR2/ CD340/anti-ERBB2/ EGFR2/ CD340
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1601

Category:

G

Proteo Genix logo

Petosemtamab Biosimilar – Anti-EGFR/ ERBB1/ LGR5 mAb – Research Grade

Target: EGFR/ ERBB1/ LGR5
Target Alias Name: Petosemtamab /MCLA-158/EGFR/ ERBB1/ LGR5/anti-EGFR/ ERBB1/ LGR5
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1059

Category:

G

Proteo Genix logo

Pexelizumab Biosimilar – Anti-C5 mAb – Research Grade

Target: C5
Target Alias Name: Pexelizumab/5G1.1-SC/C5/anti-C5
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: scFv-nd-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1963

Category:

G

Proteo Genix logo

Picankibart Biosimilar – Anti-SGRF mAb – Research Grade

Target: SGRF
Target Alias Name: anti-SGRF/ IL-23-A/ IL-23 subunit alpha/ Interleukin-23 subunit p19/ IL23A/ Interleukin-23 subunit alpha/ IL-23p19
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1312

Category:

G

Proteo Genix logo

Pidilizumab Biosimilar – Anti-PDCD1/ CD279 mAb – Research Grade

Target: PDCD1/ CD279
Target Alias Name: Pidilizumab/CT-011/PDCD1/ CD279/anti-PDCD1/ CD279
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo